Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_assertion type Assertion NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_head.
- NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_provenance.
- NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_assertion evidence source_evidence_literature NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_provenance.
- NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_assertion SIO_000772 12835728 NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_provenance.
- NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_assertion wasDerivedFrom befree-20140225 NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_provenance.
- NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_assertion wasGeneratedBy ECO_0000203 NP163594.RAmw8iZe4lf9kJHaIh51B9igiQoDGClbud6C-4WvwYCpY130_provenance.